FGF-23 Antibody (C-term 225-244)
A goat polyclonal antibody to human FGF-23.
Product Specifications
| Citations | 6 |
|---|---|
| Clonality | Polyclonal |
| Immnogen | Synthetic peptide corresponding to amino acids 225-244 of human FGF-23 |
| Applications | See citations and technical data sheet for application info. |
| Concentration | Varies (refer to CoA) |
| Conjugate | Unconjugated |
| Cross Reactivity | None |
Ordering Information
| Catalog Number | 21-6120 |
|---|---|
| Catalog Number (CE) | N/A |
| Size | 100 µg |
| Price (USD) | $385.00 |
| Price (EURO) | 340,00 € |
Contact us
| US Phone | +1 (858) 552 1100 |
|---|---|
| EU Phone | +353 (91) 412 474 |
| US Email | contact-us@quidelortho.com |
| EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
| Description | A goat polyclonal antibody to human FGF-23. |
|---|---|
| Size | 100 µg |
| Concentration | Varies (refer to CoA) |
| Applications | See citations and technical data sheet for application info. |
| Form | Liquid. 0.01M PBS (pH 7.4 ± 0.2), with 0.1% Sodium Azide. |
| Clonality | Polyclonal |
| Immunogen | Synthetic peptide corresponding to amino acids 225-244 of human FGF-23 |
| Conjugate | Unconjugated |
| Cross Reactivity | None |
| Isotype | Goat IgG |
| Purity | Affinity purified |
| Source | Goat |
| Specificity | The specificity of the antibody was established via series of immunoassays. |
| Storage | Short term (30 days) 4˚C. Long term at or below –20˚C. |
| Background | Fibroblast growth factor 23 (FGF-23), which is produced by bone cells, is a novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins. |
Citations
| Title | Year | Applications | Sample Species | Sample | Sample Details |
|---|---|---|---|---|---|
| 2019 | IHC | Human | Neurofibromas | ||
| 2019 | IHC | Human | Skin Tissue | ||
Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients | 2015 | IHC, WB | Human | Bone Tissue | |
FGF23 protein expression in coronary arteries is associated with impaired kidney function | 2014 | IHC | Human | Artery Tissue | |
Biological variability of plasma intact and C-terminal FGF23 measurements | 2012 | IP, WB | Human | Plasma | N/A |
| 2010 | WB | Human | Plasma |
Certificate of Analysis
